The rates of progression of human immunodeficiency virus (HIV) infection and survival have been reported to differ among sociodemographic groups.
It is unclear whether these differences reflect biologic differences or differences in access to medical care.
We measured disease progression and survival in a cohort of 1372 patients seropositive for HIV who were treated at a single urban center (median follow-up, 1.6 years).
We calculated the rates of survival for the entire cohort and the rates of progression to the acquired immunodeficiency syndrome (AIDS) or death among the 740 patients who presented without AIDS.
There was no relation between disease progression and sex, race, injection-drug use, income, level of education, or insurance status.
There was no significant difference in survival between men and women, blacks and whites, injection-drug users and those who did not use drugs, or patients whose median annual incomes were $5,000 or less and those whose incomes were more than $5,000.
Among patients with HIV infection who received medical care from a single urban center, there were no differences in disease progression or survival associated with sex, race, injection-drug use, or socioeconomic status.
Differences found in other studies may reflect differences in the use of medical care.
(N Engl J Med 1995 ; 333 : 751-6.).
Mots-clés Pascal : Infection, Virus immunodéficience humaine, Lentivirinae, Retroviridae, Virus, Epidémiologie, Influence, Race, Sexe, Toxicomanie, Substance toxicomanogène, Etude cohorte, Homme, Immunodéficit, Immunopathologie
Mots-clés Pascal anglais : Infection, Human immunodeficiency virus, Lentivirinae, Retroviridae, Virus, Epidemiology, Influence, Race, Sex, Drug addiction, Drug of abuse, Cohort study, Human, Immune deficiency, Immunopathology
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0536916
Code Inist : 002B06D01. Création : 01/03/1996.